SCHEMBL25459747

SCHEMBL25459747

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4nc(-c5cccc(-c6ccc7c8ccccc8c8ccccc8c7c6)c5)sc4c3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 6/20 0.51
▸ KDM4E B2RXH2 6/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ NFKB1 P19838 5/20 0.49
▸ NFKB2 Q00653 5/20 0.49
▸ RELA Q04206 5/20 0.49
▸ LMNA P02545 2/20 0.49
▸ MAPT P10636 6/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ GAA P10253 4/20 0.48
▸ GLA P06280 3/20 0.48
▸ HPGD P15428 3/20 0.48
▸ PKM P14618 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ RAB9A P51151 6/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ POLB P06746 3/20 0.47
▸ TP53 P04637 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459745 0.94 KDM4E (0.53) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL25459568 0.90 KDM4E (0.46) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL27258687 0.85 APP (0.47) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL27049206 0.85 KDM4E (0.65) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL22352440 0.84 ADORA2A (0.39) KDM4ESMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL26535822 0.84 RAB9A (0.61) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL27258765 0.84 RAB9A (0.61) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL26535744 0.84 RAB9A (0.61) APPKDM4ESMN1; SMN2NFKB1NFKB2
SCHEMBL22352438 0.84 ADORA2A (0.39) KDM4ESMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL26535825 0.84 RAB9A (0.61) APPKDM4ESMN1; SMN2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX APP 869/4885KDM4E 2446/4885SMN1; SMN2 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback